Ligand Pharmaceuticals Incorporated
LGND
Jodie situation report
Ligand Pharmaceuticals Incorporated's current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 16 directly disclosed connections are confirming.
- LGND's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if LGND's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind LGND
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
AMGNAmgen Inc.partnerMay 8, 2026 ▾
“We have established multiple alliances, licenses and other business relationships with the world’s leading biopharmaceutical companies including Amgen, Merck, Pfizer, Jazz, Gilead Sciences and Baxter.”
GILDGilead Sciences, Inc.partnerMay 8, 2026 ▾
“We have established multiple alliances, licenses and other business relationships with the world’s leading biopharmaceutical companies including Amgen, Merck, Pfizer, Jazz, Gilead Sciences and Baxter.”
Depended on by
PVLAPalvella Therapeutics, Inc.partnerMay 7, 2026 ▾
“Under the Ligand Agreement, Ligand has made payments totaling $15.0 million to fund the development of QTORIN rapamycin.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 13 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
LGND is currently a Leader in the organic co-movement group Biotechnology. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for LGND; it is not active in the latest market snapshot.